Fresh analysis indicates that people who stop using popular slimming jabs like Wegovy and Mounjaro can put back on lost weight at a significantly accelerated pace than those who stop traditional lifestyle programs.
Published data in a prominent health publication points out that while obese individuals frequently drop about a fifth of their total mass while using the jabs, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing these medications need to be aware of the danger of quick rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
That rate of regain implies a reversion to original mass in about a year and a half.
Weighing Approaches
The research, which examined dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.
The team point out that individuals who lose weight through dieting usually have a more gradual creep back—around 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Nutrition scientists believe the mechanism of the drugs is key to understanding the amplified rebound.
These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Long-term administration of GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making binge eating far more likely."
An Ongoing Disease?
Medical guidelines suggest the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Many experts contend that, given the significant potential of weight regain, the treatment is often ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the findings "emphasize the long-term nature of obesity," akin to managing conditions like high blood pressure.
User Experiences
Individuals who have discontinued the medication explain a powerful resurgence of cravings.
"I experienced a switch flipping and I was suddenly ravenous," said a patient.
The struggle is worsened if patients have not developed permanent dietary or behavioural modifications during therapy.
Significant Interest
Recent estimates show that a significant number of adults in the UK have tried these injections in the past year, with interest being substantial.
- Use is more common among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Ultimately, clinicians emphasize that while these medications are effective agents for weight loss, they are not a magic solution and lasting health benefits hinges on integrated behavioural changes.